|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00347165 |
|
Date of registration:
|
29/06/2006 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Intravitreal Bevacizumab for Age-Related Macular Degeneration
|
|
Scientific title:
|
Intravitreal Bevacizumab Therapy for Neovascular Age-Related Macular Degeneration: A Pilot Study |
|
Date of first enrolment:
|
September 2005 |
|
Target sample size:
|
50 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00347165 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
Phase:
|
Phase 2
|
|
|
Countries of recruitment
|
|
Mexico
| | | | | | | |
|
Contacts
|
|
Name:
|
Hugo Quiroz-Mercado, MD |
|
Address:
|
|
|
Telephone:
|
525510841400 |
|
Email:
|
retinamex@yahoo.com |
|
Affiliation:
|
|
|
|
Name:
|
Hugo Quiroz-Mercado, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Asociación para Evitar la Ceguera en México |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- age >50 age related macular degeneration
Exclusion Criteria:
- moderate to severe cataract glaucoma intraocular surgery diabetes mellitus non
controlled hypertension coronary artery disease
Age minimum:
50 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Age Related Macular Degeneration
|
|
Intervention(s)
|
|
Drug: bevacizumab intravitreal injection
|
|
Primary Outcome(s)
|
|
Improvement of visual acuity at 6 months
|
|
Secondary Outcome(s)
|
|
Leakiness in fluorangiography at 6 months
|
|
Retinal thickness at 6 months
|
|
Secondary ID(s)
|
|
AvastinDMRE
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|